ORBIMED ADVISORS LLC

Q3 2024 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2024
Date filed
11/14/2024
Form type
13F-HR
Num holdings
119
Total value ($000)
$5,503,519
Net value change ($000)
+438,993 (8.7%)
New positions
19
Sold out positions
18
Turnover %
9.9%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 8/14/2024 Next filing: 2/14/2025 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
EWTX 130,389 48.2%
MBX 99,041 NEW
QTTB 60,087 148.6%
UNH 47,621 83.5%
SPRY 41,543 52.8%
AMGN 39,144 92.9%
UHS 35,726 NEW
ITGR 34,314 84.9%
SYK 32,891 35.9%
BIOA 29,608 NEW
Top Reduces (Value $000, Stocks/ETFs)
JANX -67,648 -54.2%
BIIB -51,255 -24.5%
VRNA -41,382 -100.0%
GERN -37,864 -100.0%
ELV -35,863 -39.4%
DXCM -32,869 -100.0%
NBIX -26,882 -43.6%
THC -26,116 -16.7%
HRTX -22,795 -100.0%
MORPHIC HLDG INC -20,868 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 38,623 (0.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIMED CAPITAL LLC 028-10410